nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—SCNN1A—germ cell cancer	0.899	1	CbGaD
Triamterene—Irreversible renal failure—Cisplatin—germ cell cancer	0.00782	0.219	CcSEcCtD
Triamterene—SCNN1D—Stimuli-sensing channels—SCNN1A—germ cell cancer	0.00363	0.138	CbGpPWpGaD
Triamterene—SCNN1B—Stimuli-sensing channels—SCNN1A—germ cell cancer	0.00363	0.138	CbGpPWpGaD
Triamterene—SCNN1G—Stimuli-sensing channels—SCNN1A—germ cell cancer	0.00363	0.138	CbGpPWpGaD
Triamterene—Renal failure chronic—Ifosfamide—germ cell cancer	0.00318	0.0891	CcSEcCtD
Triamterene—Renal failure chronic—Cisplatin—germ cell cancer	0.00274	0.0768	CcSEcCtD
Triamterene—SCNN1B—Ion channel transport—SCNN1A—germ cell cancer	0.00237	0.0903	CbGpPWpGaD
Triamterene—SCNN1G—Ion channel transport—SCNN1A—germ cell cancer	0.00237	0.0903	CbGpPWpGaD
Triamterene—SCNN1D—Ion channel transport—SCNN1A—germ cell cancer	0.00237	0.0903	CbGpPWpGaD
Triamterene—SCNN1D—telencephalon—germ cell cancer	0.0021	0.0539	CbGeAlD
Triamterene—SCNN1D—gonad—germ cell cancer	0.00176	0.045	CbGeAlD
Triamterene—Anaemia megaloblastic—Methotrexate—germ cell cancer	0.00172	0.0482	CcSEcCtD
Triamterene—SCNN1G—pituitary gland—germ cell cancer	0.00171	0.0439	CbGeAlD
Triamterene—SCNN1B—decidua—germ cell cancer	0.00168	0.0432	CbGeAlD
Triamterene—SCNN1A—telencephalon—germ cell cancer	0.00164	0.0421	CbGeAlD
Triamterene—SCNN1A—decidua—germ cell cancer	0.00156	0.0399	CbGeAlD
Triamterene—SCNN1D—adrenal gland—germ cell cancer	0.00153	0.0392	CbGeAlD
Triamterene—CYP1A2—urine—germ cell cancer	0.0015	0.0385	CbGeAlD
Triamterene—SCNN1B—gonad—germ cell cancer	0.00148	0.038	CbGeAlD
Triamterene—SCNN1A—uterus—germ cell cancer	0.00136	0.0349	CbGeAlD
Triamterene—SCNN1A—pituitary gland—germ cell cancer	0.00134	0.0343	CbGeAlD
Triamterene—SCNN1D—endocrine gland—germ cell cancer	0.00133	0.034	CbGeAlD
Triamterene—SCNN1D—head—germ cell cancer	0.00131	0.0336	CbGeAlD
Triamterene—SCNN1B—adrenal gland—germ cell cancer	0.00129	0.0331	CbGeAlD
Triamterene—SCNN1D—testis—germ cell cancer	0.00127	0.0324	CbGeAlD
Triamterene—SCNN1A—adrenal gland—germ cell cancer	0.00119	0.0306	CbGeAlD
Triamterene—SCNN1G—cerebellum—germ cell cancer	0.00117	0.03	CbGeAlD
Triamterene—SCNN1D—cerebellum—germ cell cancer	0.00117	0.03	CbGeAlD
Triamterene—SCNN1B—endocrine gland—germ cell cancer	0.00112	0.0287	CbGeAlD
Triamterene—Tubulointerstitial nephritis—Ifosfamide—germ cell cancer	0.00112	0.0313	CcSEcCtD
Triamterene—SCNN1A—female gonad—germ cell cancer	0.00111	0.0286	CbGeAlD
Triamterene—SCNN1B—head—germ cell cancer	0.00111	0.0284	CbGeAlD
Triamterene—SCNN1B—testis—germ cell cancer	0.00107	0.0274	CbGeAlD
Triamterene—SCNN1A—endocrine gland—germ cell cancer	0.00104	0.0266	CbGeAlD
Triamterene—SCNN1A—head—germ cell cancer	0.00102	0.0262	CbGeAlD
Triamterene—SCNN1A—testis—germ cell cancer	0.000988	0.0253	CbGeAlD
Triamterene—SCNN1D—brain—germ cell cancer	0.000949	0.0243	CbGeAlD
Triamterene—SCNN1D—lymph node—germ cell cancer	0.000917	0.0235	CbGeAlD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000825	0.0314	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000825	0.0314	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000825	0.0314	CbGpPWpGaD
Triamterene—SCNN1B—brain—germ cell cancer	0.000802	0.0206	CbGeAlD
Triamterene—SCNN1B—lymph node—germ cell cancer	0.000775	0.0199	CbGeAlD
Triamterene—Azotaemia—Methotrexate—germ cell cancer	0.000759	0.0213	CcSEcCtD
Triamterene—SCNN1A—brain—germ cell cancer	0.000741	0.019	CbGeAlD
Triamterene—Hyperkalaemia—Cisplatin—germ cell cancer	0.000724	0.0203	CcSEcCtD
Triamterene—SCNN1A—lymph node—germ cell cancer	0.000716	0.0184	CbGeAlD
Triamterene—Renal failure acute—Ifosfamide—germ cell cancer	0.000672	0.0189	CcSEcCtD
Triamterene—Renal failure acute—Cisplatin—germ cell cancer	0.00058	0.0163	CcSEcCtD
Triamterene—Hypokalaemia—Ifosfamide—germ cell cancer	0.000565	0.0159	CcSEcCtD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000539	0.0206	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000539	0.0206	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000539	0.0206	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000539	0.0206	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000531	0.0202	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000531	0.0202	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000531	0.0202	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000531	0.0202	CbGpPWpGaD
Triamterene—Hypokalaemia—Cisplatin—germ cell cancer	0.000487	0.0137	CcSEcCtD
Triamterene—Thrombocytopenia—Vinblastine—germ cell cancer	0.000414	0.0116	CcSEcCtD
Triamterene—Jaundice—Etoposide—germ cell cancer	0.000368	0.0103	CcSEcCtD
Triamterene—Anaphylactic shock—Bleomycin—germ cell cancer	0.000357	0.01	CcSEcCtD
Triamterene—Thrombocytopenia—Bleomycin—germ cell cancer	0.00035	0.00981	CcSEcCtD
Triamterene—Photosensitivity—Methotrexate—germ cell cancer	0.000334	0.00938	CcSEcCtD
Triamterene—CYP1A2—Metapathway biotransformation—NAT9—germ cell cancer	0.000334	0.0127	CbGpPWpGaD
Triamterene—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000326	0.00915	CcSEcCtD
Triamterene—Renal failure acute—Methotrexate—germ cell cancer	0.000318	0.00893	CcSEcCtD
Triamterene—Hypersensitivity—Vinblastine—germ cell cancer	0.000311	0.00874	CcSEcCtD
Triamterene—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000305	0.00856	CcSEcCtD
Triamterene—Asthenia—Vinblastine—germ cell cancer	0.000303	0.00851	CcSEcCtD
Triamterene—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000299	0.00838	CcSEcCtD
Triamterene—Diarrhoea—Vinblastine—germ cell cancer	0.000289	0.00811	CcSEcCtD
Triamterene—Fatigue—Dactinomycin—germ cell cancer	0.000287	0.00805	CcSEcCtD
Triamterene—Dizziness—Vinblastine—germ cell cancer	0.00028	0.00784	CcSEcCtD
Triamterene—Vomiting—Vinblastine—germ cell cancer	0.000269	0.00754	CcSEcCtD
Triamterene—Headache—Vinblastine—germ cell cancer	0.000265	0.00743	CcSEcCtD
Triamterene—Fatigue—Ifosfamide—germ cell cancer	0.000263	0.00738	CcSEcCtD
Triamterene—Anaphylactic shock—Cisplatin—germ cell cancer	0.000263	0.00738	CcSEcCtD
Triamterene—Hypersensitivity—Bleomycin—germ cell cancer	0.000263	0.00738	CcSEcCtD
Triamterene—Thrombocytopenia—Cisplatin—germ cell cancer	0.000258	0.00723	CcSEcCtD
Triamterene—Asthenia—Bleomycin—germ cell cancer	0.000256	0.00719	CcSEcCtD
Triamterene—Nausea—Vinblastine—germ cell cancer	0.000251	0.00704	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000249	0.00948	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000249	0.00948	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000249	0.00948	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000249	0.00948	CbGpPWpGaD
Triamterene—CYP1A2—endocrine gland—germ cell cancer	0.000249	0.00638	CbGeAlD
Triamterene—Hypersensitivity—Dactinomycin—germ cell cancer	0.000245	0.00688	CcSEcCtD
Triamterene—Anaphylactic shock—Etoposide—germ cell cancer	0.000241	0.00676	CcSEcCtD
Triamterene—Asthenia—Dactinomycin—germ cell cancer	0.000239	0.0067	CcSEcCtD
Triamterene—Thrombocytopenia—Etoposide—germ cell cancer	0.000236	0.00662	CcSEcCtD
Triamterene—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000232	0.0065	CcSEcCtD
Triamterene—Diarrhoea—Dactinomycin—germ cell cancer	0.000228	0.00639	CcSEcCtD
Triamterene—Vomiting—Bleomycin—germ cell cancer	0.000227	0.00637	CcSEcCtD
Triamterene—Rash—Bleomycin—germ cell cancer	0.000225	0.00632	CcSEcCtD
Triamterene—Dermatitis—Bleomycin—germ cell cancer	0.000225	0.00631	CcSEcCtD
Triamterene—Hypersensitivity—Ifosfamide—germ cell cancer	0.000225	0.00631	CcSEcCtD
Triamterene—Asthenia—Ifosfamide—germ cell cancer	0.000219	0.00614	CcSEcCtD
Triamterene—Nausea—Bleomycin—germ cell cancer	0.000212	0.00595	CcSEcCtD
Triamterene—Vomiting—Dactinomycin—germ cell cancer	0.000212	0.00594	CcSEcCtD
Triamterene—Rash—Dactinomycin—germ cell cancer	0.00021	0.00589	CcSEcCtD
Triamterene—Diarrhoea—Ifosfamide—germ cell cancer	0.000209	0.00586	CcSEcCtD
Triamterene—Fatigue—Etoposide—germ cell cancer	0.000208	0.00583	CcSEcCtD
Triamterene—Dizziness—Ifosfamide—germ cell cancer	0.000202	0.00566	CcSEcCtD
Triamterene—Nausea—Dactinomycin—germ cell cancer	0.000198	0.00555	CcSEcCtD
Triamterene—Vomiting—Ifosfamide—germ cell cancer	0.000194	0.00544	CcSEcCtD
Triamterene—Hypersensitivity—Cisplatin—germ cell cancer	0.000194	0.00544	CcSEcCtD
Triamterene—Rash—Ifosfamide—germ cell cancer	0.000192	0.0054	CcSEcCtD
Triamterene—Dermatitis—Ifosfamide—germ cell cancer	0.000192	0.00539	CcSEcCtD
Triamterene—Asthenia—Cisplatin—germ cell cancer	0.000189	0.0053	CcSEcCtD
Triamterene—Nausea—Ifosfamide—germ cell cancer	0.000181	0.00509	CcSEcCtD
Triamterene—Diarrhoea—Cisplatin—germ cell cancer	0.00018	0.00505	CcSEcCtD
Triamterene—Hypersensitivity—Etoposide—germ cell cancer	0.000178	0.00498	CcSEcCtD
Triamterene—Asthenia—Etoposide—germ cell cancer	0.000173	0.00485	CcSEcCtD
Triamterene—Vomiting—Cisplatin—germ cell cancer	0.000167	0.00469	CcSEcCtD
Triamterene—Rash—Cisplatin—germ cell cancer	0.000166	0.00465	CcSEcCtD
Triamterene—Dermatitis—Cisplatin—germ cell cancer	0.000166	0.00465	CcSEcCtD
Triamterene—Diarrhoea—Etoposide—germ cell cancer	0.000165	0.00463	CcSEcCtD
Triamterene—Dizziness—Etoposide—germ cell cancer	0.000159	0.00447	CcSEcCtD
Triamterene—Nausea—Cisplatin—germ cell cancer	0.000156	0.00438	CcSEcCtD
Triamterene—Vomiting—Etoposide—germ cell cancer	0.000153	0.0043	CcSEcCtD
Triamterene—Rash—Etoposide—germ cell cancer	0.000152	0.00426	CcSEcCtD
Triamterene—Dermatitis—Etoposide—germ cell cancer	0.000152	0.00426	CcSEcCtD
Triamterene—Headache—Etoposide—germ cell cancer	0.000151	0.00424	CcSEcCtD
Triamterene—Anaphylactic shock—Methotrexate—germ cell cancer	0.000144	0.00405	CcSEcCtD
Triamterene—Nausea—Etoposide—germ cell cancer	0.000143	0.00402	CcSEcCtD
Triamterene—Thrombocytopenia—Methotrexate—germ cell cancer	0.000141	0.00397	CcSEcCtD
Triamterene—Fatigue—Methotrexate—germ cell cancer	0.000124	0.00349	CcSEcCtD
Triamterene—Hypersensitivity—Methotrexate—germ cell cancer	0.000106	0.00298	CcSEcCtD
Triamterene—Asthenia—Methotrexate—germ cell cancer	0.000104	0.00291	CcSEcCtD
Triamterene—Diarrhoea—Methotrexate—germ cell cancer	9.88e-05	0.00277	CcSEcCtD
Triamterene—Dizziness—Methotrexate—germ cell cancer	9.55e-05	0.00268	CcSEcCtD
Triamterene—Vomiting—Methotrexate—germ cell cancer	9.18e-05	0.00258	CcSEcCtD
Triamterene—Rash—Methotrexate—germ cell cancer	9.1e-05	0.00255	CcSEcCtD
Triamterene—Dermatitis—Methotrexate—germ cell cancer	9.09e-05	0.00255	CcSEcCtD
Triamterene—Headache—Methotrexate—germ cell cancer	9.04e-05	0.00254	CcSEcCtD
Triamterene—Nausea—Methotrexate—germ cell cancer	8.57e-05	0.00241	CcSEcCtD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	4.68e-05	0.00178	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	3.67e-05	0.0014	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.83e-05	0.00108	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC2A3—germ cell cancer	1.57e-05	0.000599	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—SLC22A3—germ cell cancer	1.55e-05	0.00059	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CRABP1—germ cell cancer	1.26e-05	0.000481	CbGpPWpGaD
